ICTR’s Allan Brasier and WARF Therapeutics’ Jon Young highlight new opportunities for moving solutions from the lab to the patient. Plus, a panel of campus experts – Jennifer Golden, Doug McNeel and Luigi Puglielli – share their pharma development experiences.